Early Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning

• URL: http://arxiv.org/abs/2602.22285v1
• Date: Wed, 25 Feb 2026 13:29:48 GMT
• Title: Early Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning
• Authors: Félicien Hêche, Sohrab Ferdowsi, Anthony Yazdani, Sara Sansaloni-Pastor, Douglas Teodoro,
• Abstract summary: The objective of this study is to develop a machine learning (ML)-based framework for early risk stratification of clinical trials (CTs)<n>We constructed a dataset from ClinicalTrials.gov comprising 42,112 CTs.<n>CTs were assigned binary labels indicating elevated dosing error rate, derived from adverse event reports, MedDRA terminology, and Wilson confidence intervals.
• Score: 1.626552847072743
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Objective: The objective of this study is to develop a machine learning (ML)-based framework for early risk stratification of clinical trials (CTs) according to their likelihood of exhibiting a high rate of dosing errors, using information available prior to trial initiation. Materials and Methods: We constructed a dataset from ClinicalTrials.gov comprising 42,112 CTs. Structured, semi-structured trial data, and unstructured protocol-related free-text data were extracted. CTs were assigned binary labels indicating elevated dosing error rate, derived from adverse event reports, MedDRA terminology, and Wilson confidence intervals. We evaluated an XGBoost model trained on structured features, a ClinicalModernBERT model using textual data, and a simple late-fusion model combining both modalities. Post-hoc probability calibration was applied to enable interpretable, trial-level risk stratification. Results: The late-fusion model achieved the highest AUC-ROC (0.862). Beyond discrimination, calibrated outputs enabled robust stratification of CTs into predefined risk categories. The proportion of trials labeled as having an excessively high dosing error rate increased monotonically across higher predicted risk groups and aligned with the corresponding predicted probability ranges. Discussion: These findings indicate that dosing error risk can be anticipated at the trial level using pre-initiation information. Probability calibration was essential for translating model outputs into reliable and interpretable risk categories, while simple multimodal integration yielded performance gains without requiring complex architectures. Conclusion: This study introduces a reproducible and scalable ML framework for early, trial-level risk stratification of CTs at risk of high dosing error rates, supporting proactive, risk-based quality management in clinical research.

Related papers

• Suppressing Prior-Comparison Hallucinations in Radiology Report Generation via Semantically Decoupled Latent Steering [94.37535002230504]
  We develop a training-free, inference-time control framework termed Semantically Decoupled Latent Steering.<n>Our approach constructs a semantic-free intervention vector via large language model (LLM)-driven semantic decomposition.<n>We show that our approach significantly reduces the probability of historical hallucinations.
  arXiv  Detail & Related papers  (2026-02-27T04:49:01Z)
• Breast Cancer Recurrence Risk Prediction Based on Multiple Instance Learning [0.0]
  This study investigates the potential of computational pathology to stratify patients using deep learning on routine Hematoxylin and Eosin stained whole-slide images (WSIs)<n>We developed and compared three Multiple Instance Learning frameworks -- CLAM-SB, ABMIL, and ConvNeXt-MIL-XGBoost -- on an in-house dataset of 210 patient cases.<n>In a 5-fold cross-validation, the modified CLAM-SB model demonstrated the strongest performance, achieving a mean Area Under the Curve (AUC) of 0.836 and a classification accuracy of 76.2%.
  arXiv  Detail & Related papers  (2025-12-21T13:46:50Z)
• Overlap-weighted orthogonal meta-learner for treatment effect estimation over time [90.46786193198744]
  We introduce a novel overlap-weighted meta-learner for estimating heterogeneous treatment effects (HTEs)<n>Our WO-learner has the favorable property of Neyman-orthogonality, meaning that it is robust against misspecification in the nuisance functions.<n>We show that our WO-learner is fully model-agnostic and can be applied to any machine learning model.
  arXiv  Detail & Related papers  (2025-10-22T14:47:57Z)
• Deep Survival Analysis for Competing Risk Modeling with Functional Covariates and Missing Data Imputation [13.108896747775063]
  We introduce the Functional Competing Risk Net (FCRN), a unified deep-learning framework for discrete-time survival analysis under competing risks.<n>By combining a micro-network Basis Layer for functional data representation with a gradient-based imputation module, FCRN simultaneously learns to impute missing values and predict event-specific hazards.
  arXiv  Detail & Related papers  (2025-09-29T18:33:00Z)
• LLM-Augmented Symptom Analysis for Cardiovascular Disease Risk Prediction: A Clinical NLP [2.2615384250361004]
  This study introduces a novel LLM-augmented clinical NLP pipeline that employs domain-adapted large language models for symptom extraction, contextual reasoning, and correlation from free-text reports.<n> Evaluations on MIMIC-III and CARDIO-NLP datasets demonstrate improved performance in precision, recall, F1-score, and AUROC, with high clinical relevance.
  arXiv  Detail & Related papers  (2025-07-15T07:32:16Z)
• Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models [70.64969663547703]
  AdaCVD is an adaptable CVD risk prediction framework built on large language models extensively fine-tuned on over half a million participants from the UK Biobank.<n>It addresses key clinical challenges across three dimensions: it flexibly incorporates comprehensive yet variable patient information; it seamlessly integrates both structured data and unstructured text; and it rapidly adapts to new patient populations using minimal additional data.
  arXiv  Detail & Related papers  (2025-05-30T14:42:02Z)
• Prediction-Powered Causal Inferences [59.98498488132307]
  We focus on Prediction-Powered Causal Inferences (PPCI)<n>We first show that conditional calibration guarantees valid PPCI at population level.<n>We then introduce a sufficient representation constraint transferring validity across experiments.
  arXiv  Detail & Related papers  (2025-02-10T10:52:17Z)
• Risk and cross validation in ridge regression with correlated samples [72.59731158970894]
  We provide training examples for the in- and out-of-sample risks of ridge regression when the data points have arbitrary correlations.<n>We demonstrate that in this setting, the generalized cross validation estimator (GCV) fails to correctly predict the out-of-sample risk.<n>We further extend our analysis to the case where the test point has nontrivial correlations with the training set, a setting often encountered in time series forecasting.
  arXiv  Detail & Related papers  (2024-08-08T17:27:29Z)
• Modeling Long Sequences in Bladder Cancer Recurrence: A Comparative Evaluation of LSTM,Transformer,and Mamba [0.0]
  This study integrates the advantages of deep learning models for handling long-sequence data with the Cox proportional hazards model. The LSTM-Cox model is a robust and efficient method for recurrent data analysis and feature extraction,surpassing newer models like Transformer and Mamba.
  arXiv  Detail & Related papers  (2024-05-28T18:38:15Z)
• A Generalized Unbiased Risk Estimator for Learning with Augmented Classes [70.20752731393938]
  Given unlabeled data, an unbiased risk estimator (URE) can be derived, which can be minimized for LAC with theoretical guarantees. We propose a generalized URE that can be equipped with arbitrary loss functions while maintaining the theoretical guarantees.
  arXiv  Detail & Related papers  (2023-06-12T06:52:04Z)
• SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction [68.8204255655161]
  We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data. Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function. SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
  arXiv  Detail & Related papers  (2022-04-20T17:28:08Z)
• A New Approach for Interpretability and Reliability in Clinical Risk Prediction: Acute Coronary Syndrome Scenario [0.33927193323747895]
  We intend to create a new risk assessment methodology that combines the best characteristics of both risk score and machine learning models. The proposed approach achieved testing results identical to the standard LR, but offers superior interpretability and personalization. The reliability estimation of individual predictions presented a great correlation with the misclassifications rate.
  arXiv  Detail & Related papers  (2021-10-15T19:33:46Z)
• Active Deep Learning on Entity Resolution by Risk Sampling [5.219701379581547]
  Active Learning (AL) presents itself as a feasible solution that focuses on data deemed useful for model training. We propose a novel AL approach of risk sampling for entity resolution (ER) Based on the core-set characterization for AL, we theoretically derive an optimization model which aims to minimize core-set loss with non-uniform continuity. We empirically verify the efficacy of the proposed approach on real data by a comparative study.
  arXiv  Detail & Related papers  (2020-12-23T20:38:25Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.